⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL257782 | 0.83 | — | — | |
| SCHEMBL10172359 | 0.83 | — | — | |
| SCHEMBL3437770 | 0.77 | — | — | |
| SCHEMBL3885964 | 0.77 | — | — | |
| SCHEMBL22912378 | 0.77 | — | — | |
| SCHEMBL3889600 | 0.77 | — | — | |
| SCHEMBL13777327 | 0.77 | — | — | |
| SCHEMBL13980712 | 0.77 | — | — | |
| SCHEMBL15008861 | 0.72 | — | — | |
| Lithium Ion SCHEMBL3437769 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4282899-A1 | POLY(PHENYLENE ETHER), PRODUCTION METHOD THEREFOR, THERMALLY CURABLE COMPOSITION, PREPREG, AND LAMINATE | Asahi Kasei Kabushiki Kaisha (JP) | 2023-11-29 | — | — | EP | disclosed |
| US-20230371357-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-16 | — | — | US | disclosed |
| US-20230354690-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-02 | — | — | US | disclosed |
| US-20230320190-A1 | ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-10-05 | — | — | US | disclosed |
| US-20230181604-A1 | Use of Mitochondria-Targeted Antioxidants to Treat Severe Inflammatory Conditions | MITOTECH S.A. (LU) | 2023-06-15 | — | — | US | disclosed |
| US-20230061438-A1 | METHODS OF SEQUENCING BY SYNTHESIS USING A CONSECUTIVE LABELING SCHEME | Roche Sequencing Solutions, Inc. | 2023-03-02 | — | — | US | disclosed |
| US-20230038070-A1 | POLYMER MATRIXES FOR DIFFERENT COMPOSITIONS OF MITOCHONDRIALLY TARGETED ANTIOXIDANTS | MITOTECH S.A. (LU) | 2023-02-09 | — | — | US | disclosed |
| US-20220049065-A1 | Foam Bead and Sintered Foam Structure | DOW GLOBAL TECHNOLOGIES LLC | 2022-02-17 | — | — | US | disclosed |
| US-11131130-B2 | Plastic living hinges with block composite polymer | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-09-28 | — | — | US | disclosed |
| WO-2020230870-A1 | COPPER-CLAD LAMINATED PLATE, RESIN-CLAD COPPER FOIL, AND CIRCUIT SUBSTRATE USING SAID PLATE AND FOIL | パナソニックＩＰマネジメント株式会社 | 2020-11-19 | — | — | WO | disclosed |
| US-20170342559-A1 | METHOD FOR FORMING CARBON-CONTAINING SILICON/METAL OXIDE OR NITRIDE FILM BY ALD USING SILICON PRECURSOR AND HYDROCARBON PRECURSOR | ASM IP HOLDING B.V. (NL) | 2017-11-30 | — | — | US | disclosed |
| US-20170258807-A1 | SUBSTITUTED TRIAZOLOBENZODIAZEPINES | CONCERT PHARMACEUTICALS, INC. (US) | 2017-09-14 | — | — | US | disclosed |
| US-20170247607-A1 | CURABLE COMPOSITION AND RESIN FOR TREATMENT OF A SUBTERRANEAN FORMATION | HALLIBURTON ENERGY SERVICES, INC. (US) | 2017-08-31 | — | — | US | disclosed |
| US-9744180-B2 | Pharmaceutical formulations containing mitochondrially targeted antioxidants | MITOTECH SA (LU) | 2017-08-29 | — | — | US | disclosed |
| US-9724313-B2 | Pharmaceutical composition for use in medical and veterinary ophthalmology | MITOTECH SA (LU) | 2017-08-08 | — | — | US | disclosed |
| US-9694017-B2 | Substituted triazolobenzodiazepines | CONCERT PHARMACEUTICALS, INC. (US) | 2017-07-04 | — | — | US | disclosed |
| US-9127105-B2 | Supported metallocene catalysts | FINA TECHNOLOGY, INC. (US) | 2015-09-08 | — | — | US | disclosed |
| US-20080003344-A1 | Seasoning and method for seasoning a food product while reducing dietary sodium intake | GIVAUDAN FLAVORS CORPORATION | 2008-01-03 | — | — | US | disclosed |
| WO-2005082379-A1 | MYOCARDIAL PERFUSION IMAGING USING ADENOSINE RECEPTOR AGONISTS | CV THERAPEUTICS, INC. (US) | 2005-09-09 | — | — | WO | disclosed |
| WO-2004011010-A1 | MYOCARDIAL PERFUSION IMAGING USING A2A RECEPTOR AGONISTS | CV THERAPEUTICS, INC. (US) | 2004-02-05 | — | — | WO | disclosed |